Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Sabba Stephen L, Director. Insider active across 1 company, notably Ligand Pharmaceuticals INC. In total, 8 reports have been logged. Activity tracked since 4 June 2021. The latest transaction was disclosed on 1 April 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
8 of 8 declarations
Stephen L. Sabba is a Board Member at Ligand Pharmaceuticals Inc. He plays a vital role in overseeing the company's activities and developing strategies aimed at fostering innovation and growth. His experience in the pharmaceutical sector is beneficial for the organization.